Implant survival rates and biologic complications with implant-supported fixed complete dental prostheses: A retrospective study with up to 12-year follow-up.

Autor: Papaspyridakos P; Division of Postgraduate Prosthodontics, Tufts University School of Dental Medicine, Boston, Massachusetts.; Department of Prosthodontics, University of Rochester Eastman Institute for Oral Health, Rochester, New York., Barizan Bordin T; Division of Postgraduate Prosthodontics, Tufts University School of Dental Medicine, Boston, Massachusetts.; Division of Postgraduate Prosthodontics, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil., Kim YJ; Division of Postgraduate Prosthodontics, Tufts University School of Dental Medicine, Boston, Massachusetts., DeFuria C; Division of Postgraduate Prosthodontics, Tufts University School of Dental Medicine, Boston, Massachusetts., Pagni SE; Department of Public Health and Community Service, Tufts University School of Dental Medicine, Boston, Massachusetts., Chochlidakis K; Department of Prosthodontics, University of Rochester Eastman Institute for Oral Health, Rochester, New York., Rolim Teixeira E; Division of Postgraduate Prosthodontics, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil., Weber HP; Division of Postgraduate Prosthodontics, Tufts University School of Dental Medicine, Boston, Massachusetts.
Jazyk: angličtina
Zdroj: Clinical oral implants research [Clin Oral Implants Res] 2018 Aug; Vol. 29 (8), pp. 881-893. Date of Electronic Publication: 2018 Jul 24.
DOI: 10.1111/clr.13340
Abstrakt: Objectives: To assess the rate of biologic complications and implant survival in edentulous patients treated with implant-supported fixed complete dental prostheses (IFCDPs) after a mean observation period of 5.2 years (range: 1-12 years).
Materials and Methods: A single-visit clinical and radiographic examination was performed to assess types and rates of biologic complications with ceramic IFCDPs (Group 1) and metal-resin IFCDPs (Group 2).
Results: Of 457 rough surface dental implants supporting 71 IFCDPs (52 patients), six had failed, yielding an implant survival rate of 98.7% after a mean observation period of 5.2 years after definitive prosthesis insertion. The most frequent minor biologic complication was soft tissue recession (7.7% annual rate), inflammation under the IFCDP (7.4% annual rate), and peri-implant mucositis (6.3% annual rate). The most frequent major biologic complication was peri-implantitis (2.0% annual rate), in 46/457 implants (10.1%) supporting 19 IFCDPs and late implant failure (0.3% annual rate). The frequency of biologic complications was not statistically different between Group 1 and Group 2. The presence of high plaque index had significant effect on bone loss.
Conclusions: After a mean exposure time of 5.2 years postdefinitive prosthesis insertion (range: 1-12 years), implant survival rate of 98.7% was achieved. The six implant failures in three patients occurred after 5 years and affected the prosthesis survival. Soft tissue recession was the most frequent minor biologic complication, whereas peri-implantitis was the most frequent major biologic complication. A 10-year implant-based mucosal recession rate of 77% (95% CI: 68.2-87.9) and a 10-year implant-based peri-implantitis rate of 20% (95% CI: 16.9-24.9) were found.
(© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: